The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2020

Filed:

Nov. 10, 2017
Applicant:

Sirna Therapeutics, Inc., Cambridge, MA (US);

Inventors:

Lee Lim, San Francisco, CA (US);

Guillaume Chorn, San Francisco, CA (US);

Aarron T. Willingham, San Francisco, CA (US);

Lihong Zhao, Walnut Creek, CA (US);

Assignee:

SIRNA THERAPEUTICS, INC., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C12N 15/111 (2013.01); C12N 15/1138 (2013.01); C12N 2310/14 (2013.01); C12N 2310/141 (2013.01); C12N 2310/318 (2013.01); C12N 2310/3183 (2013.01); C12N 2310/332 (2013.01); C12N 2310/344 (2013.01); C12N 2310/351 (2013.01); C12N 2310/3515 (2013.01); C12N 2310/3519 (2013.01);
Abstract

The instant disclosure features single-stranded RNA molecules comprising one or more internal, non-nucleotide spacers. A non-nucleotide spacer covalently links nucleotide portions of the molecule. The single-stranded RNA molecules function as guide or antisense strands that are capable of inhibiting gene expression via an RNA interference mechanism and, thus, represent single-stranded RNAi agents. The single-stranded RNAi molecules can be used in methods for a variety of therapeutic, diagnostic, target validation, genomic discovery, genetic engineering, and pharmacogenomic applications.


Find Patent Forward Citations

Loading…